Moberg Pharma AB (publ)
F:MB8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Moberg Pharma AB (publ)
F:MB8
|
SE |
|
M
|
Madison Square Garden Sports Corp
F:MS8
|
US |
Intrinsic Value
The intrinsic value of 
Moberg Pharma AB (publ) (MB8) under the Base Case is 0.349 EUR per share.
Compared with the current market price of 0.944 EUR, the stock appears
Overvalued by 63% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Moberg Pharma AB Does
Moberg Pharma is a Swedish specialty pharmaceutical company that develops and sells branded over-the-counter treatments, mainly for nail and skin problems such as nail fungus. Its products are designed for self-care, so the company is focused on treatments people can buy without a doctor’s prescription. It also works with partners and distributors to sell its brands in different markets.
- Headquarters
- Sweden SE
- IPO date
- May 26, 2011
Revenue & Expenses Breakdown
Moberg Pharma AB (publ)
Earnings Waterfall
Moberg Pharma AB (publ)
The intrinsic value for Moberg Pharma AB (publ) (MB8) under the Base Case is 0.349 EUR.
Compared with the current market price of 0.944 EUR, the stock appears Overvalued by 63% .